Advertisement
Home »

Mechanisms of primary resistance to immune checkpoint inhibitors in NSCLC.

Sep 23, 2024

ABOUT THE EXPERTS

  • Georgia Gomatou

    Oncology Unit, Third Department of Medicine, “Sotiria” General Hospital for Chest Diseases, National and Kapodistrian University of Athens, Athens, Greece. georgiagom@med.uoa.gr.

    Andriani Charpidou

    Oncology Unit, Third Department of Medicine, “Sotiria” General Hospital for Chest Diseases, National and Kapodistrian University of Athens, Athens, Greece.

    Peifeng Li

    Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.

    Nikolaos Syrigos

    Oncology Unit, Third Department of Medicine, “Sotiria” General Hospital for Chest Diseases, National and Kapodistrian University of Athens, Athens, Greece.

    Ioannis Gkiozos

    Oncology Unit, Third Department of Medicine, “Sotiria” General Hospital for Chest Diseases, National and Kapodistrian University of Athens, Athens, Greece.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement